Inavolisib: observed
3 studies: patients on it are followed, or it is given outside a trial. Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Risk-Stratified Management of Inavolisib-Induced Hyperglycemia and Patient AdherenceRecruitingNCT07817056Report a problem
- A Real-World Study of Inavolisib in Patients With HR-Positive/HER2-Negative, PIK3CA-Mutated Advanced Breast CancerNot yet recruitingNCT07543250Report a problem
- A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast CancerRecruitingNCT07347600Report a problem